XRAY 241220 22.50P (XRAY241220P22500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

XRAY241220P22500

Watchlist

3.70
-1.34-26.59%

15min DelayClose Dec 20 16:00 ET

3.70High3.70Low

Intraday

5D
Daily

News

Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 34% Undervaluation?
Simply Wall StDec 21 07:57 ET
Dentsply Sirona Is Maintained at Overweight by Morgan Stanley
Dow JonesDec 17 12:12 ET · Ratings
Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Cuts Target Price to $23
Moomoo NewsDec 17 09:31 ET · Ratings
DENTSPLY SIRONA (XRAY) Receives a Buy From Morgan Stanley
TipRanksDec 17 08:35 ET · Ratings
Worst Performing Stocks for Tax Loss Selling – Wolfe
Seeking AlphaDec 16 14:59 ET
Dentsply Sirona To Go Ex-Dividend On December 27th, 2024 With 0.16 USD Dividend Per Share
Moomoo NewsDec 13 20:35 ET

Comments

Moomoo AI

Feb 16 08:24

The company's low growth and lack of profits have led to a stock price drop. A revenue growth acceleration might boost the share price. However, the real benefit for shareholders will be if the company starts making profits. Despite recent gains, the returns over the last three years have been disappointing.

DENTSPLY SIRONA (NASDAQ:XRAY) Shareholders Have Endured a 32% Loss From Investing in the Stock Three Years Ago

Moomoo AI

Jan 29 07:51

DENTSPLY SIRONA's decreasing capital employment and flat returns are concerning. The stock's decline may reflect investor pessimism about these trends. The analysis does not see the traits of a multi-bagger in this stock.

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Moomoo AI

Dec 24, 2023 08:55

DENTSPLY SIRONA's decision to pay a dividend amidst a reported loss is unsettling. It's not an ideal choice for long-term buy and hold investors.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Goes Ex-Dividend Soon

Moomoo AI

Dec 18, 2023 13:16

Investors predict limited future growth for the company, reflected by its low P/S ratio. The pessimism around its revenue prospect contributes to its undervalued stock.

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Moomoo AI

Nov 28, 2023 05:33

DENTSPLY SIRONA, currently undervalued with steady price trends, could make a solid investment. Despite modest growth projections, aspects like capital structure and management track record could be behind its undervaluation.

Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$31.48?